Targeting the tumor promoting effects of adenosine in chronic lymphocytic leukemia

Critical Reviews in Oncology/hematology
Yiqing CaiXin Wang

Abstract

Chronic lymphocytic leukemia (CLL) is a hematological malignancy which is characterized by progressive accumulation of functionally deficient B cells in blood, bone marrow, and lymphatic tissue. The tumor microenvironment (TME) appears to play a critical role in genesis and progression of CLL. High levels of extracellular adenosine (ADO) are detected in CLL as a consequence of expression of ecto-enzymes, such as CD39 and CD73. Extracellular ADO exhibits a broad range of effects on cell cycle control, immunoregulation, angiogenesis and cytokine regulation through both direct and indirect mechanisms. In this review, we focused on the multiple functions and related mechanisms of ADO signaling in CLL generation and progression.

Citations

Apr 14, 2020·Cancer Cell International·Li-Li FengXin Wang
Oct 20, 2020·Frontiers in Immunology·Hajer AounallahMichail Kotsyfakis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Related Papers

Ryōikibetsu shōkōgun shirīzu
S Ito, S Kuriya
Seikagaku. The Journal of Japanese Biochemical Society
Hiroki Tsukamoto
Current Topics in Microbiology and Immunology
Klaus Okkenhaug, Jan A Burger
© 2022 Meta ULC. All rights reserved